UNSPSC 51411803: Fenoxedil

This classification denotes a vasodilating agent with the molecular formula C28H42N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ABX8234H6M, chemically known as 2-(p-butoxyphenoxy)-n-(2,5-diethoxyphenyl)-n-(2-(diethylamino)ethyl)acetamide but generally known as fenoxedil, which bears US NIH Compound Identifier 71731. European Medicines Agency schedules Fenoxedil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07582MIG.

UNSPSC 51411803 Fenoxedil is a Commodity code covering pharmaceutical active ingredients and finished medications procured by state and local emergency medical services, health agencies, and cooperative purchasing alliances. State and local governments buy under this code to stock emergency medications, fill pharmacy benefit program needs, and support direct-to-manufacturer procurement initiatives. The City of Tampa's Fire Rescue, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the range of issuing bodies — municipal emergency services, state health agencies, and multi-state cooperative purchasing vehicles — that solicit medications and pharmaceutical products to support clinical operations, patient care, and cost management across their jurisdictions.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa issued IFB 26P00188 for Advanced Life Support Medications on April 24, 2026, seeking 370 units of Labetalol HCI, 1,810 units of Epinephrine 1:10,000, 330 units of Adenosine 6mg, and 1,020 units of Diltiazem 25mg vials with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00, with a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026 to explore vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 on January 20, 2026 due March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026 and a two-year term. All three solicitations require vendor compliance with FDA standards, Good Manufacturing Practices, and expiration-date warranties; the Tampa and MMCAP opportunities name specific wholesaler relationships and administrative fee structures.